Research and Development Focused Equities Outperform NSE 500 Over Five Years

Indian companies that increased their spending on research and development (R&D) surpassed the performance of the NSE 500 Total Return Index (TRI) across a five-year period, generating an average annualised return of 23.5%. Firms that successfully paired strong research expansion with elevated R&D intensity delivered an average annualised return of 32.5%. These findings underscore the growing commercial value of business innovation for equity investors. Corporate spending on research and development serves as a key indicator of a company's ability to create proprietary products, maintain pricing power, and adapt to changing technological landscapes.

Markets often reward innovative firms with higher valuations because sustained R&D investment creates long-term competitive advantages that protect profit margins against commoditization. Analyzing R&D intensity helps institutional investors identify forward-looking businesses capable of outperforming standard market indices. Portfolio managers and equity researchers should incorporate corporate R&D metrics into their fundamental screening models to identify high-growth investment candidates.

Investors must evaluate whether increased research spending effectively translates into commercial revenue and bottom-line growth rather than just expense expansion. Bottom line: companies prioritizing disciplined research and development deliver superior long-term returns for equity investors.